open access
Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism
Affiliations- Department of Interventional Cardiology, Cardiology and Angiology II, University Heart Center Freiburg — Bad Krozingen, Germany
- Gottsegen György Hungarian Institute of Cardiology, Budapest, Hungary
open access
Abstract
Abstract
About this articleTitle
Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism
Journal
Issue
Article type
Letter to the Editor
Pages
642-645
Published online
2021-02-27
Page views
648
Article views/downloads
560
DOI
10.5603/CJ.a2021.0027
Pubmed
Bibliographic record
Cardiol J 2021;28(4):642-645.
Authors
Peter Tajti
Mohamed Ayoub
Thomas Nuehrenberg
Kambis Mashayekhi
References (11)- Marraccini P, Bianchi M, Bottoni A, et al. Prevalence of thyroid dysfunction and effect of contrast medium on thyroid metabolism in cardiac patients undergoing coronary angiography. Acta Radiol. 2013; 54(1): 42–47.
- Hintze G, Blombach O, Fink H, et al. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol. 1999; 140(3): 264–267.
- Bonelli N, Rossetto R, Castagno D, et al. Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status. Clin Endocrinol (Oxf). 2018; 88(2): 272–278.
- Rieger J, Sitter T, Toepfer M, et al. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant. 2002; 17(5): 824–828.
- Sayin T, Turhan S, Akyürek O, et al. Gadolinium:nonionic contrast media (1:1) coronary angiography in patients with impaired renal function. Angiology. 2007; 58(5): 561–564.
- Juneman E, Saleh L, Thai H, et al. The use of gadolinium in patients with contrast allergy or renal failure requiring coronary angiography, coronary intervention, or vascular procedure. Catheter Cardiovasc Interv. 2011; 78(5): 747–754.
- Cubero-Gómez J, Márquez FG, la-Llera LDd, et al. Severe thrombocytopenia induced by iodinated contrast after coronary angiography: The use of gadolinium contrast and intravascular ultrasound as an alternative to guide percutaneous coronary intervention. Rev Port Cardiol. 2017; 36(1): 61.e1–61.e4.
- Kälsch H, Kälsch T, Eggebrecht H, et al. Gadolinium-based coronary angiography in patients with contraindication for iodinated x-ray contrast medium: a word of caution. J Interv Cardiol. 2008; 21(2): 167–174.
- Ledingham D, Carey P, Junejo S. The dangers of iodine-based contrasts in an elderly patient with thyroid disease. BMJ Case Rep. 2015; 2015.
- Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165.
- Ali ZA, Karimi Galougahi K, Nazif T, et al. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J. 2016; 37(40): 3090–3095.
